In this issue:
Sorafenib and omacetaxine mepesuccinate in FLT3-ITD AML
Karyotype and prognosis in NPM1-mutated AML
Dexamethasone dose and duration in childhood ALL
Thrombosis treatment complications in Hodgkin lymphoma
Treosulfan-fludarabine conditioning before alloHSCT for AML or MDS
Obstetric and maternal outcomes in Hodgkin lymphoma
Olaptesed pegol with bendamustine and rituximab in CLL
Pembrolizumab for R/R Hodgkin lymphoma
Ibrutinib plus lenalidomide and rituximab in R/R non-GCB DLBCL
Synchronous systemic and CNS involvement of DLBCL outcomes dictated by CNS disease
Please login below to download this issue (PDF)